
Functional Technologies is commercially developing yeast strains capable of virtually eliminating, or in the least substantially reducing, ethyl carbamate levels from existing levels in wine and distilled spirits. Functional Technologies' initial products are targeted for the red and white wine, brandy, sake and distilled spirits markets.
CURRENT STATUS ON THE DEVELOPMENT OF FUNCTIONAL TECHNOLOGIES YEAST PRODUCTS:
Note: TBA = To Be Announced (awaiting results)
Achievements:
1998 to 2000: Proof of concept work was initiated and completed at the UBC Wine Research Centre.
February 2004: Successfully applied platform technology to red wine yeast and initiated testing. Expanded product development line to include four more yeast strains, which are globally and commercially used in the production of white wine, brandy and sake.
May 2004: Successfully completed testing of the red wine yeast.
June 2004: Successfully applied platform technology to brandy yeast and initiated testing. Initiated fermentation testing of the red wine yeast.
July 2004: Submitted data to "Request for Data" posting from The Food & Agriculture Organization of the United Nations and The World Health Organization (FAO/WHO) for risk assessment study on Ethyl Carbamate to be done by the Joint FAO/WHO Expert Committee On Food Additives (JECFA). Risk assessment to include toxicology, exposure and intervention strategies. JECFA evaluation due February 2005.
August 2004: Red wine yeast completed first step of fermentation testing with positive results demonstrating it could effectively and substantially break down urea. Also, successfully applied platform technology to white wine yeast and initiated fermentation testing of the brandy yeast.
November 2004: Functional Technologies' proprietary red wine and brandy yeasts successfully complete fermentation tests to confirm they substantially reduce ethyl carbamate in wine.
December 2004: Functional Technologies announces an appointment to its Advisory Board. Mr. Arthur Caputi - a 50 year executive with E. & J. Gallo Winery who is a highly respected, published and active enologist and scientist in the wine industry worldwide.
2006: Commercial field trials in Northern Hemisphere wineries.
2007: Commercial field trials in Southern Hemisphere wineries.
March 2007: WHO and IARC reclassifies ethyl carbamate from Group 2B Carcinogen to Group 2A.
|